NI
CGEM icon

Nextech Invest’s Cullinan Oncology CGEM Stock Holding History

Nextech Invest’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,141,145
Closed -$16.2M – 16
2026
Q1 		$16.2M Hold
1,141,145
– – 1.14% 11
2025
Q4 		$11.8M Hold
1,141,145
– – 1.14% 11
2025
Q3 		$6.77M Hold
1,141,145
– – 1.03% 11
2025
Q2 		$8.59M Hold
1,141,145
– – 1.63% 12
2025
Q1 		$8.64M Hold
1,141,145
– – 2.01% 10
2024
Q4 		$13.9M Hold
1,141,145
– – 2.25% 10
2024
Q3 		$19.1M Sell
1,141,145
-80,000
-7% -$1.42M 2.68% 9
2024
Q2 		$21.3M Hold
1,221,145
– – 3.58% 8
2024
Q1 		$20.8M Hold
1,221,145
– – 3.3% 8
2023
Q4 		$12.4M Hold
1,221,145
– – 2.32% 10
2023
Q3 		$11.1M Hold
1,221,145
– – 3.35% 6
2023
Q2 		$13.1M Hold
1,221,145
– – 4.47% 5
2023
Q1 		$12.5M Hold
1,221,145
– – 5.21% 5
2022
Q4 		$12.9M Hold
1,221,145
– – 5.13% 6
2022
Q3 		$15.7M Hold
1,221,145
– – 5.06% 7
2022
Q2 		$15.7M Hold
1,221,145
– – 5.28% 7
2022
Q1 		$12.8M Hold
1,221,145
– – 3.65% 9
2021
Q4 		$18.8M Buy
+1,221,145
New +$24.4M 4.96% 8

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Nextech Invest's CGEM Position: Q2 2026 in Review

Nextech Invest sold out of Cullinan Oncology (CGEM) in Q2 2026, closing a stake of 1,141,145 shares — an estimated $16.2M sold.

Nextech Invest first reported a position in CGEM in Q4 2021 and held it in 18 quarters. The position peaked at $21.3M in Q2 2024. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Nextech Invest reported no remaining Cullinan Oncology position as of Q2 2026 after selling out during the quarter.
  • Nextech Invest sold 1,141,145 Cullinan Oncology shares in Q2 2026, an estimated $16.2M.
  • Nextech Invest first reported a position in Cullinan Oncology in Q4 2021 and held it in 18 quarters.
  • Nextech Invest's Cullinan Oncology position peaked at $21.3M in Q2 2024.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Nextech Invest's 13F filing for Q2 2026, filed 14 Aug 2026.